Log In
BCIQ
Print this Print this
 

GDC-0425, RG7602

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionOrally available, small molecule checkpoint kinase 1 (Chk1) inhibitor
Molecular Target Checkpoint kinase 1 (Chk1) (CHEK1)
Mechanism of ActionKinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$713.0M

$28.0M

$685.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/15/2011

$713.0M

$28.0M

$685.0M

Get a free BioCentury trial today